Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rhodococcus equi: an emerging pathogen.

David M Weinstock1, Arthur E Brown

  • 1Department of Medicine, Infectious Disease Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|May 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Azacitidine-induced remission enables allogeneic transplantation in <i>TET2</i>/<i>BCOR</i>-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report.

Haematologica·2026
Same author

Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy.

Blood advances·2026
Same author

Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma.

Science advances·2025
Same author

Methylene blue treatment of fatal cerebral malaria and identification of potential blood biomarkers.

Nature communications·2025
Same author

Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma.

Leukemia·2025
Same author

Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell Lymphoma.

bioRxiv : the preprint server for biology·2025
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Rhodococcus equi infections primarily affect immunocompromised individuals, often those with HIV. Diagnosis can be challenging due to potential misidentification as contaminants, and treatment requires prolonged management with a risk of relapse.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Immunocompromised Host

Background:

  • Rhodococcus equi is an emerging pathogen causing human disease.
  • Over 100 human cases have been reported since its initial description.
  • The majority of infected individuals are immunocompromised, with a high prevalence of HIV co-infection.

Purpose of the Study:

  • To summarize the history, diagnosis, clinical features, and treatment of Rhodococcus equi infections.
  • To highlight the challenges in identifying and managing this pathogen.

Main Methods:

  • Literature review of reported cases.
  • Analysis of clinical manifestations and diagnostic findings.
  • Summary of treatment strategies and outcomes.

Related Experiment Videos

Main Results:

  • Rhodococcus equi infections present with diverse clinical manifestations, frequently involving the pulmonary system (80% of cases).
  • The organism is culturable but may be misdiagnosed as a contaminant.
  • Treatment is often prolonged, and relapses are common.

Conclusions:

  • Rhodococcus equi is a significant pathogen in immunocompromised populations.
  • Early and accurate diagnosis is crucial for effective management.
  • Prolonged treatment and vigilance for relapses are necessary.